Safety and efficacy of atezolizumab (atezo) in patients (pts) with autoimmune disease (AID): Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma
暂无分享,去创建一个
R. Huddart | C. Sternberg | F. Massari | Y. Loriot | A. Fay | E. Choy | S. Oosting | I. Skoneczna | P. Maroto | C. Sacco | F. Nolè | H. Dumez | D. C. Gauna | S. Fear | T. A. Gordoa | K. Vianna | S. D. Ducla | F. D. Nucci | B. Brasiuniene